SG
Swarthmore Group’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $624K | Sell |
4,076
-51,224
| -93% | -$7.84M | 0.25% | 7 |
|
|
2022
Q1 | $8.97M | Sell |
55,300
-592
| -1% | -$96K | 2.29% | 7 |
|
|
2021
Q4 | $7.57M | Buy |
+55,892
| New | +$7.57M | 1.8% | 17 |
|
|
2018
Q1 | – | Sell |
-3,275
| Closed | -$317K | – | 33 |
|
|
2017
Q4 | $317K | Sell |
3,275
-350
| -10% | -$33.9K | 0.07% | 45 |
|
|
2017
Q3 | $322K | Buy |
+3,625
| New | +$322K | 0.07% | 48 |
|
|
2016
Q4 | – | Sell |
-342,350
| Closed | -$21.6M | – | 52 |
|
|
2016
Q3 | $21.6M | Sell |
342,350
-7,850
| -2% | -$495K | 4.13% | 6 |
|
|
2016
Q2 | $21.7M | Sell |
350,200
-97,850
| -22% | -$6.06M | 3.68% | 7 |
|
|
2016
Q1 | $25.6M | Sell |
448,050
-160,500
| -26% | -$9.17M | 3.91% | 8 |
|
|
2015
Q4 | $36.1M | Sell |
608,550
-54,200
| -8% | -$3.21M | 3.86% | 10 |
|
|
2015
Q3 | $36.1M | Buy |
662,750
+5,000
| +0.8% | +$272K | 3.83% | 11 |
|
|
2015
Q2 | $44.2M | Sell |
657,750
-56,925
| -8% | -$3.82M | 4.11% | 6 |
|
|
2015
Q1 | $41.8M | Sell |
714,675
-23,300
| -3% | -$1.36M | 3.81% | 8 |
|
|
2014
Q4 | $48.3M | Sell |
737,975
-24,175
| -3% | -$1.58M | 4.38% | 7 |
|
|
2014
Q3 | $44M | Buy |
762,150
+108,725
| +17% | +$6.28M | 4.08% | 5 |
|
|
2014
Q2 | $36.9M | Sell |
653,425
-17,950
| -3% | -$1.01M | 3.88% | 7 |
|
|
2014
Q1 | $34.5M | Buy |
671,375
+53,250
| +9% | +$2.74M | 4.08% | 8 |
|
|
2013
Q4 | $32.6M | Sell |
618,125
-12,150
| -2% | -$642K | 3.8% | 10 |
|
|
2013
Q3 | $28.2M | Buy |
630,275
+9,500
| +2% | +$425K | 3.61% | 17 |
|
|
2013
Q2 | $25.7M | Buy |
+620,775
| New | +$25.7M | 3.25% | 18 |
|